GIP & GLP-1 · 5 mg/0.5 mL
Tirzepatide
Dual GIP & GLP-1. Higher potency, physician-managed. Reviewed individually, delivered discreetly.
By physician consultation
Clinical Overview
How Tirzepatide works
The first medication in its class to engage two metabolic pathways at once — and the reason its trial outcomes set a new ceiling.
Engages the GIP receptor
Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight-management medications do not address.
Engages the GLP-1 receptor
At the same time it echoes GLP-1 — regulating appetite and slowing how quickly food leaves the stomach.
Combined metabolic effect
The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.
Candidacy Profiling
A considered fit, not a funnel.
Adults ready for the most advanced GLP-1-class protocol — with the individual oversight and titration discipline this higher-potency medication requires.
- Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions
- Patients who have plateaued on a single-agonist GLP-1 and want to escalate under physician guidance
- Members for whom faster onset and higher trial averages are clinically appropriate
- Personal or family history of medullary thyroid carcinoma or MEN 2
- Pregnancy, breastfeeding, or planning pregnancy
- Active pancreatitis or untreated severe gastrointestinal disease
Expected Timeline
What to expect
Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your physician titrates carefully to the dose that fits your body.
-
01
Month 1
Titration
Faster initial response than single-agonist GLP-1s. Careful, physician-managed escalation begins.
-
02
Month 3
Established
Therapeutic dose reached. Strong metabolic momentum; appetite consistently regulated.
-
03
Month 6
~20%
Average body weight reduction in published trials. Many members exceed this range.
-
04
Year 1+
Sustained
Sustained reduction for the majority of members who remain in the program.
Outcomes referenced from SURMOUNT-1 trial data. Individual results vary with starting weight, dose, and adherence.
Your Concierge Support
A licensed clinician, matched to you.
BioPivot is directed by a team of licensed, U.S. board-certified physicians specializing in GLP-1 weight loss and metabolic wellness. Every protocol is reviewed and personally approved by a physician, with direct, secure messaging on your schedule — and a team that stays with you through every step.
- 01Compounded medication
- Prepared by partner compounding pharmacies and shipped on a structured cadence.
- 02Physician-guided care
- Every interaction is guided directly by our licensed care team — not a rotating call center.
- 03Physician-managed dosing
- Titration and adjustments at every transition, reviewed individually by your physician.
- 04Direct message access
- Reach your physician directly between scheduled check-ins through your secure patient portal.
- 05Structured check-ins
- Cadenced reviews that keep your protocol and wellness plan tuned to your response.
- 06Discreet delivery
- Temperature-controlled, unmarked packaging delivered discreetly to your door.
The BioPivot Standard
Physician-guided care, reviewed individually — and delivered to your door, discreetly.
- 01.Physician-Led
- A licensed U.S. physician designs and personally approves your protocol — and only when it's clinically appropriate.
- 02.Reviewed Individually
- No one-size-fits-all. Every plan is titrated to your biology and your goals, then adjusted as you progress.
- 03.Delivered Discreetly
- Care arrives at your door in private, unbranded packaging — with your team a secure message away.
Clinical Safety
No medication is right for everyone.
Common side effects
Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and settle as your body adjusts to each step of the protocol.
Clinical Contraindications
Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.
BioPivot protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — guided by your physician — and delivered discreetly to your door.
Clinical Experience
From members of the Tirzepatide program.
-
“
I had done six months on Semaglutide and plateaued. Moving to Tirzepatide was a second wind. The results picked up again and I feel like myself.
-
“
Honestly the pace surprised me. By week three I was setting reminders to eat — never my problem before. My energy is up and my labs are the best they have been in a decade.
-
“
I wondered whether the higher-potency route was right for me. My physician walked me through it honestly, and the individual review made the decision easy.
Frequently Asked
Questions worth asking before you begin.
-
Every program begins with an online consultation. If your physician authorizes treatment, your protocol is prepared by a partner compounding pharmacy and delivered discreetly to your door, with structured check-ins and direct messaging access to your physician throughout.
-
We keep it transparent. Our programs use flat-rate pricing with no hidden fees, no consultation charges, and no dose-change surcharges. The price we quote is the price you pay.
-
BioPivot operates via telehealth across the states where we are licensed.
-
Your consultation is reviewed individually and authorized by a licensed physician. Every patient receives consistent, licensed clinical care with direct messaging access.
-
Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.
-
Yes. Your medical information is shared only with your assigned physician and the dispensing pharmacy. We never sell or share your data.
Comparison Protocol
Semaglutide
The single-agonist GLP-1 foundation. Lower trial averages, often the right place to start.
Begin Consultation
The Tirzepatide program begins with a conversation.
Your consultation is reviewed by your dedicated provider. If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.